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Abstract
Background: DNA microarrays are used to investigate differences in gene expression between
two or more classes of samples. Most currently used approaches compare mean expression levels
between classes and are not geared to find genes whose expression is significantly different in only
a subset of samples in a class. However, biological variability can lead to situations where key genes
are differentially expressed in only a subset of samples. To facilitate the identification of such genes,
a new method is reported.
Methods:  The key difference between the Population Proportion Ranking Method (PPRM)
presented here and almost all other methods currently used is in the quantification of variability.
PPRM quantifies variability in terms of inter-sample ratios and can be used to calculate the relative
merit of differentially expressed genes with a specified difference in expression level between at
least some samples in the two classes, which at the same time have lower than a specified variability
within each class.
Results: PPRM is tested on simulated data and on three publicly available cancer data sets. It is
compared to the t test, PPST, COPA, OS, ORT and MOST using the simulated data. Under the
conditions tested, it performs as well or better than the other methods tested under low intra-
class variability and better than t test, PPST, COPA and OS when a gene is differentially expressed
in only a subset of samples. It performs better than ORT and MOST in recognizing non differentially
expressed genes with high variability in expression levels across all samples. For biological data, the
success of predictor genes identified in appropriately classifying an independent sample is reported.
Background
DNA microarrays are used to monitor the expression level
of thousands of genes simultaneously, and are extensively
used in various areas of biological research [1-4]. The
reader is referred to Schena [5] and Bowtell and Sambrook
[6] for a detailed introduction to microarray technology.
A biological problem which is being increasingly
addressed through the use of microarray assays is the
identification of differences in gene expression between
two or more classes of samples e.g. between disease and
normal tissue [7-18]. The methods for identifying differ-
entially expressed genes vary greatly [19-27], but all have
a goal of identifying genes with a significant difference in
expression level between samples in the two classes. A
simple method to analyze such data is to compare the
sample means of the expression level of each gene in the
two classes to obtain a 'fold-change' [28] in the expression
level of the gene between the two classes. However, fold
change calculations fail to account for variability in
expression levels between samples within a class. As aptly
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pointed out by Simon et al [29], "some twofold average
effects represent statistically significant differences and
some do not". Statistical methods like t-test [30,31] and
ANOVA [32-34] are used to assess the significance of dif-
ferential expression by incorporating data on variability
between samples. Many alternative approaches of incor-
porating data on variability have also been developed [19-
21,26,27,35].
Unlike the case of replicate in vitro data which are expected
to have extremely low intra-class variability under ideal
conditions, the expression level of a gene can vary signifi-
cantly within samples obtained from different individuals
in one class due to biological variation [36]. Also, clini-
cally similar phenotypes can be caused by different molec-
ular mechanisms [37]. Genes which are differentially
expressed in only a subset of samples in a class can be
important in such cases [38-40]. Most analysis methods
compare the means of intra-class expression levels and are
not likely to find genes whose expression is significantly
different in only a subset of samples in a class, or have
high intra-class variability.
A few approaches have been previously proposed to iden-
tify such genes [38,39,41-43]. One approach to identify
such genes proposed by Lyons-Weiler et al [39], is the Per-
mutation Percentile Separability Test (PPST). This test
identifies genes for which a statistically significant
number of samples in group A exhibit expression intensi-
ties beyond a particular percentile of the observed expres-
sion intensities of that gene in group B. Another approach
is proposed by Bijlani et al [38] who compare the expres-
sion level of a gene in every sample in one class to the
mean of the expression level in the other class. The pro-
posed application of this method is to select genes which
can be used for class distinction. Tomlins et al [42], Tib-
shirani et al [41], Wu et al [43] and Lian et al [44] use var-
iations of transformation of gene expression values using
the sample median and median absolute deviation in the
Cancer Outlier Profile Analysis (COPA), Outlier sums
(OS), Outlier Robust t-statistics (ORT) and Maximum
Ordered Subset t-statistics (MOST) methods respectively.
The performance of COPA and OS has been shown to
deteriorate as the number of outliers increase [43].
All the methods listed above except PPST use some nor-
malized form of the algebraic difference between expres-
sion levels as a measure of heterogeneity to identify
'outliers'. These methods might not be suitable for cases
where a subset of samples in a class are responsible for sig-
nificantly increasing the variability in the class, and are
spread over a large range. Consider the following hypo-
thetical example; a group of 10 samples have expression
levels of a gene as [50, 50, 75, 80, 100, 120, 120, 300, 500,
and 700]. Defining an outlier as a value more than the
interquartile range above the third quartile, as used by
some researchers [43], only one sample (700) is identified
as an outlier. However a closer look at the data indicates
that the last three samples are responsible for the
increased variability in the class. This motivated the need
to explore alternative ways to quantify variability.
This paper presents a Population Proportion Ranking
Method (henceforth referred to as PPRM) to qualitatively
rank differentially expressed genes. This method uses
inter-sample ratios to quantify variability in expression
levels. To my knowledge, this is the first reported method
using this approach. The method allows the user to pre-
define the required magnitude of difference in expression
level of a gene between samples in the two classes and the
allowable level of intra-class variability, and has the abil-
ity to identify genes which might be differentially
expressed in only a subset of the samples in a class and
have high variability within a class. The basic steps in the
method are outlined in Figure 1. Briefly, the inter-class
variability is quantified by calculating the ratio of expres-
sion level of a sample in class T (Treated) to its expression
level in a sample in class N (Normal), for all possible
combinations of samples in the two classes (referred to
henceforth as interclass ratios). Depending on the desired
relative difference between the classes to identify a gene as
differentially expressed, an inter-class ratio cutoff is cho-
sen. The higher the inter-class ratio cutoff, the greater the
required difference between classes. The fraction of inter-
class ratios calculated above, which are greater than this
inter-class ratio cutoff, is calculated (fTN). A higher value
of fTN implies that a larger proportion of samples have the
required difference between the two classes.
Intra-class variability for a class is similarly quantified by
calculating the ratios of expression level of a sample in the
class to its expression level in every other sample in the
same class (referred to henceforth as intra-class ratios).
Analogous to the inter-class ratio cutoff, an intra-class
ratio cutoff is chosen based on acceptable level of variabil-
ity within a class. The fraction of intra-class ratios calcu-
lated above which are greater than the cutoff is calculated
(fTT & fNN). Genes in which these fractions are significantly
smaller than fTN are ranked based on an established statis-
tical method of comparing population proportions [45].
Simulated data sets where the truly differentially
expressed genes are known are used to test the ability of
PPRM to identify differentially expressed genes. The per-
formance of PPRM is compared to the t test, PPST[39],
COPA [42], OS [41], ORT [43] and MOST [44] for the
simulated data, and is found to be comparable or better
under the conditions tested. Thus, PPRM could be a valu-
able addition to the repertoire of existing methods for
detecting genes differentially expressed in a subset of sam-BMC Bioinformatics 2008, 9:380 http://www.biomedcentral.com/1471-2105/9/380
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ples in a class. However, simulated data sets do not neces-
sarily mimic the variability in real biological data sets.
Hence, this method is also applied to three publicly avail-
able cancer data sets to identify differentially expressed
genes.
Since there is no gold standard of true differentially
expressed genes in an experimental study, an approach of
using differentially expressed genes identified by the
method as predictors to test their ability to successfully
classify independent sample(s) is used for validation of
the method in real-world data. This approach was also
used by Jeffery et al for evaluation of lists of differentially
expressed genes identified [46]. The method proposed in
this paper is tested on 3 publicly available cancer data sets:
leukemia [18], colon cancer [47] and prostate cancer [48].
In case of the leukemia data set, an independent sample
set is available to test whether the top differentially
expressed genes identified can correctly classify independ-
ent samples. For the other two data sets, leave-one-out
cross-validation (LOOCV) is implemented to test the
accuracy of classification.
The particular method of choice for identifying differen-
tially expressed genes depends on the biological question,
and PPRM provides an additional tool to rank genes com-
plying with a given set of constraints.
Results
In this section, the Population Proportion Ranking
Method (PPRM) is described, followed by a discussion on
the assumptions used in PPRM and results of testing of
this method on simulated and experimental data.
Population Proportion Ranking Method
Let the number of samples in class T (for 'Treated') be mT
and the number of samples in class N (for Normal) be
mN. Ti, for i = 1 to mT, are the expression levels of a gene
in the mT samples of class T and Nj, for j = 1 to mN, are the
expression levels of the gene in the mN samples of class N.
The inter-class variability is quantified using ratio  ,
defined below:
R TN
ij ,
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Summary of the Population Proportion Ranking Method Figure 1
Summary of the Population Proportion Ranking 
Method. The inter-class variability is quantified by calculating 
the inter-class ratio of expression level of a sample in class T 
to its expression level in a sample in class N, for all possible 
combinations of samples in the two classes. Depending on 
the desired relative difference between the classes to identify 
a gene as differentially expressed, an inter-class ratio cutoff is 
chosen. The fraction of inter-class ratios calculated above, 
which are greater than this inter-class ratio cutoff, is calcu-
lated (fTN). Intra-class variability for a class is similarly quanti-
fied by calculating the intra-class ratios of expression level of 
a sample in the class to its expression level in every other 
sample in the same class. Analogous to the inter-class ratio 
cutoff, an intra-class ratio cutoff is chosen based on accepta-
ble level of variability within a class. The fraction of intra-class 
ratios calculated above which are greater than the cutoff is 
calculated (fTT, fNN). Genes in which fTT and/or fNN fraction is 
significantly smaller than fTN are ranked based on an estab-
lished statistical method of comparing population propor-
tions.BMC Bioinformatics 2008, 9:380 http://www.biomedcentral.com/1471-2105/9/380
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The intra-class variability is quantified using ratios 
and   defined below:
and
A ratio-cutoff is chosen based on biological knowledge of
the magnitude of difference in expression level required
between groups (CTN) and amount of variability that is
acceptable within groups (CTT and CNN). For example, an
inter-class ratio cutoff of 3 implies that there should be at
least a 3 fold difference in expression between a sample in
class T and another sample in class N for the gene to be
identified as differentially expressed for that pair of sam-
ples and an intra-class ratio cutoff of 1.5 means that the
maximum acceptable difference in expression between
any two samples in a class is 1.5 fold. Increasing CTN will
lead to identification of genes which have a larger magni-
tude of difference between the two classes, while changing
intra-class ratios (CTT and CNN) allows the user to change
the magnitude of variability acceptable within a given
class. Naturally, since increasing CTN or decreasing CTT or
CNN leads to a decrease in the number of genes identified
as differentially expressed, these parameters can be used
to identify a tractable number of differentially expressed
genes of a certain nature, for further analysis.
To identify differentially expressed genes, the fraction of
the inter-class ratios   which are either greater than the
ratio-cutoff CTN or smaller than 1/CTN is calculated as fTN.
Similarly the fraction of intra-class ratios   and 
which are either greater than the ratio-cutoff CTT and CNN
respectively or smaller than 1/CTT and 1/CNN respectively
are calculated as fTT and fNN.
Thus,
Genes for which fTN is significantly greater than fTT and fNN
are calculated using a standard statistical test of compar-
ing population proportions [45]. Thus, the null hypothe-
sis tested is fTN ≤ fTT and/or fTN ≤ fNN. In biological terms,
this translates to a null hypothesis that the inter class var-
iability is less than or equal to the intra class variability.
The allowable inter and intra-class variability is quantified
by their respective ratio cutoffs. The test statistic is calcu-
lated using the formula [45]:
where,
mT is the number of samples in class T
mN is the number of samples in class N
NTN is the number of ratios   which are greater than
the ratio-cutoff CTN or smaller than 1/CTN
NTT is the number of ratios   which are greater than the
ratio-cutoff CTT or smaller than 1/CTT
NNN is the number of ratios   which are greater than
the ratio-cutoff CNN or smaller than 1/CNN
The significance values pTT and pNN, corresponding to zTT
and zNN are calculated. These values indicate the signifi-
cance level of the difference between proportions of the
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inter-class ratios greater than inter-class cutoff and the
respective intra-class ratios greater than intra-class cutoff.
A p-value cut-off is chosen (pcutoff) to identify genes with
significant difference between the proportion of the inter-
class and intra-class ratios which are greater than the
respective ratio-cutoffs chosen. Thus, genes with pTT < pcut-
off and pNN < pcutoff are selected as differentially expressed.
It should be noted here that the test allows the flexibility
of controlling intra-class variability in only any one class
or in both classes. For example, differentially expressed
genes with low variability in N only can be ranked by
using the condition pNN < pcutoff and a relatively stringent
value of CNN. In summary, the three parameters which
need to be chosen to rank differentially expressed genes
are listed in Table 1.
Assumptions
The test makes an assumption of 1) Random and inde-
pendent selection of inter-class and intra-class ratios and
2) Large sample size of the inter-class ratios and inter-class
ratios, so the sampling distributions of differences of pro-
portions are very closely normally distributed. Though the
samples within each class are reasonably expected to be
selected randomly and independently, all inter- and intra-
group ratios are not independent. Specifically, there are
only (mT + mN -1) independent inter-class ratios and (mT
-1) or (mN -1) independent intra-class ratios. Hence the
effective sample size is smaller leading to smaller reported
significance values. However, in order to capture the true
variability between all samples in a group or between
groups, it is essential to use all inter-class and intra-class
ratios. Hence the reported significance values are not exact
and should only be used to calculate the relative merit of
genes, and not the actual distance between them.
Testing
PPRM is tested on 5 sets of simulated data representing
various intra and inter-class variability situations and
compared to the t test, PPST, COPA, OS, ORT and MOST.
PPST is implemented through the online implementation
provided by Lyons-Weiler et al. [39] available at http://
bioinformatics.upmc.edu/GE2/GEDA.html. COPA, OS,
ORT and MOST were implemented using the R code by
Lian [44] available at http://www.ntu.edu.sg/home/heng
lian/most.htm. PPRM is also tested on three publicly
available cancer datas and used to identify predictor genes
that can be used for classification. The classification accu-
racy using predictors identified by the PPRM is compara-
ble to other reported classification accuracies.
Simulated data
PPRM is tested on a simulated data set of 10000 genes
measured in 20 samples belonging to two classes: 10 sam-
ples in class T and 10 samples in class N. 1000 out of the
10000 genes were modeled as differentially expressed.
Simulated data sets were generated using the random
number generator function in Matlab (The Mathworks,
Inc., Natick, MA, USA) under normal distribution. To sim-
ulate the scenario where only a subset of samples within a
class are differentially expressed, in case 3, 4 and 5, it is
assumed that ~30% of the samples for the 1000 genes
show differential expression. Table 2 indicates the param-
eters for the normal distributions that were used to simu-
late the data (mean and standard deviation). Figure 2A
shows a representative example for the distribution of
expression levels across samples in the two classes for all
5 cases, using the parameters in Table 2. Figure 2B shows
the distribution of inter-class and both intra-class ratios
for all 5 cases. Data for non-differentially expressed genes
is simulated using parameters of a mean of 100 and stand-
ard deviation of 30 (not indicated in Table 2). The inter-
class ratio cutoff is chosen equal to the ratio of mean
expression level in the two classes. PPST, COPA, OS, ORT,
MOST and t test were also used to analyze the simulated
data. For COPA, OS, ORT and MOST, p-values for each
gene were calculate from the test statistics as the propor-
tion of the 9000 genes (with an identical distribution in
both classes) with absolute test statistics larger than that of
this gene [43]. A significance value cutoff of 0.01 is used
for all methods.
For all the methods, the following metrics were used to
evaluate the performance of the method.
Recall
True positives
True positives False negatives
=
+
×100
Table 1: Parameters used in the Population Proportion Ranking Method
Parameter Description Remark
CTN Ratio cutoff for inter-class ratios Chosen based on the required magnitude of difference in expression between the two classes
CTT, CNN Ratio cutoff for intra-class ratios Chosen based on allowable heterogeneity in expression within a class
pcutoff Significance value cutoff for 
significance of difference 
between the proportions of 
inter-class and intra-class 
populations greater than 
respective ratio cutoffs
Chosen based on required stringency in difference between the proportions of inter-class and 
intra-class populations greater than respective ratio cutoffsBMC Bioinformatics 2008, 9:380 http://www.biomedcentral.com/1471-2105/9/380
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where:
True positives = Number of truly differentially expressed
genes identified
False positives = Number of genes identified which are not
differentially expressed
False negatives = Number of truly differentially expressed
genes not identified
True negatives = Number of genes which are not differen-
tially expressed, which are correctly not identified
FPR = False positive rate
In order to assess the effect of violation of the assumption
of independence, the distributions of zTT and zNN were
analyzed for the simulated data. The mean and standard
distribution of zNN for all 5 cases analyzed is shown in Fig-
ure 3. The average of the means for the 9000 non- differ-
entially expressed genes across all 5 cases is 0.07, and of
the standard deviation is 1.3, while the values of the same
statistics for all 10000 genes across all 5 cases are 0.4 and
1.8 respectively. The reader is reminded that due to lack of
independence of all the inter- and intra- group ratios, the
FPR
False positives
False positives True negatives
=
+
×100
Table 2: Parameters used to generate simulated data for the 5 cases tested
Class T Class N
Number of Samples Mean Stdev* Number of Samples Mean Stdev*
Case 1 10 250 50 10 100 30
Case 2 10 250 100 10 200 100
Case 3 3 900 100 10 100 30
71 0 0 5 0
Case 4 3 400 50 5 100 30
3 300 50 5 130 30
41 0 0 3 0
Case 5 3 900 100 7 100 30
7 100 50 3 400 100
* Standard deviation
Parameters for the normal distributions used are indicated only for the 1000 differentially expressed genes. Data for the 9000 non differentially 
expressed genes is simulated using a mean of 100 and standard deviation of 30. Expression levels of samples for each case (for a representative 
example) are indicated in Figure 2A in the form of a heatmap
Distribution of expression values and inter- and intra-class ratios for all 5 cases listed in Table 2 (for a representative example)  (A) Heatmap of expression levels across samples in the two classes for all 5 cases, using the parameters in Table 2 Figure 2
Distribution of expression values and inter- and intra-class ratios for all 5 cases listed in Table 2 (for a repre-
sentative example) (A) Heatmap of expression levels across samples in the two classes for all 5 cases, using the 
parameters in Table 2. Values above 900 are indicated by the maximum intensity. (B) Heatmap of absolute values of log2 
transformed inter-class and intra-class ratios for all 5 cases. Values above 3 are indicated by the maximum intensity.
A
T1   T2   T3   T4  T5   T6   T7   T8   T9  T10  N1  N2  N3   N4  N5  N6   N7   N8  N9  N10 
Case 1
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Case 4
Case 5
B
He a t  Ma p
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Ti/Nj Ti/Tk Nj/Nl
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Case 4
Case 5
Inter-class ratios Intra-class ratios
900
0
3
0BMC Bioinformatics 2008, 9:380 http://www.biomedcentral.com/1471-2105/9/380
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p-values calculated are not exact and are to be used only
for the purpose of prioritizing and ranking genes. In all
the following discussion, the p-value cutoff is used for
selecting a subset of the top ranked differentially
expressed genes. An alternate approach would be to select
a fixed number of top ranking genes. However, in cases
where more than one gene has the same significance
value, selecting a fixed number of top ranking genes
involves randomly disregarding some genes. Hence to
avoid this, the p-value cutoff approach is used.
An ideal method will have a 100% Recall and 0% False
Positive Rate (FPR). Figure 4 summarizes the Recall and
FPR for all methods for the 5 cases described in Table 2.
The inter-class ratio cutoff (CTN) used is chosen based on
the known ratio of the means of all samples in the two
classes. The intra-class ratio cutoffs (CTT and CNN) are cho-
sen to be equal to the inter-class cutoff in all cases, with
exceptions as described below. The CTN, CTT and CNN val-
ues used for PPRM in for all 5 cases are listed in Table 3. A
significance value cutoff of 0.01 is used for all methods.
Case 1 is an example of a case of differential expression,
with low variability within samples. As seen in Figure 2B,
all intra-class ratios have small values while the inter-class
ratios are higher. PPRM, t test, ORT and MOST identify
most differentially expressed genes, with PPRM having the
lowest FPR.
Case 2 is an example of genes which do not have a signif-
icant difference in expression level in the two classes and
have larger variability as compared to case 1. Here again,
PPRM has the lowest FPR among all methods tested.
Case 3 is an example of genes which have a low variability
in one class, but very high variability in the other due to a
subset of samples. Here, the intra-class ratios for class T
are small, while those for class N are high (Figure 2B). In
this case, COPA, OS, ORT and MOST have a 100% Recall.
PPRM does not identify any differentially expressed gene
when heterogeneity in both classes is controlled (i.e. both
conditions pTT < pcutoff and pNN < pcutoff used; data not
Mean and standard distribution of zNN for all 5 cases of simulated data indicated in Table 2 Figure 3
Mean and standard distribution of zNN for all 5 cases of simulated data indicated in Table 2. The mean and stand-
ard deviation of only the 9000 non-differentially expressed genes is indicated separately from the mean and standard deviation 
of all 10000 genes. Case 1: Solid bars, Case 2: Dotted fill, Case 3: Vertical lines, Case 4: Horizontal lines, Case 5: Diagonal lines.
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Table 3: Inter-class and intra-class ratio cutoffs used in the 
analysis of simulated data using PPRM
CTN CTT CNN
Case 1 3 3 3
Case 2 1 1 1
Case 3 3 - 3
Case 4 2 - 2
Case 5 2 2 2BMC Bioinformatics 2008, 9:380 http://www.biomedcentral.com/1471-2105/9/380
Page 8 of 12
(page number not for citation purposes)
Results on the analysis of simulated data using PPRM, t test, PPST, COPA, OS, ORT and MOST Figure 4
Results on the analysis of simulated data using PPRM, t test, PPST, COPA, OS, ORT and MOST. (A) Percentage 
Recall for all 5 cases listed in Table 2 (B) Percentage FPR for all 5 cases listed in Table 2. PPRM: Blue, t test: Orange, PPST: 
Green, COPA: Brown, OS: Yellow, ORT: Red, MOST: Pink.
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shown). However, if heterogeneity in class T is allowed by
only using the condition pNN < pcutoff, PPRM has a 96%
Recall and 1% FPR, which is similar to the other methods.
This is an example of the application of PPRM allowing
the control of heterogeneity in any one class only.
Case 4 is an example of genes which have moderate vari-
ability in one class and high variability in the other. This
is different from case 3 in having the magnitude of expres-
sion level between the two classes lower (average 2-fold)
than that in case 3 (average 3-fold). Again, the t test, PPST
and OS have a poor Recall. ORT and MOST have a Recall
of 99% and 94% with a FPR of 1%. PPRM does not iden-
tify any differentially expressed gene when heterogeneity
in both classes is controlled (data not shown), but when
heterogeneity in class T is allowed (pNN < pcutoff is the only
condition used), a 98% Recall is obtained, but at the cost
of 6% FPR. There is thus a trade-off between identifying
all truly differentially expressed genes and obtaining false
positives. Increasing the stringency of the parameters (e.g.
increase in CTN, decrease in pcutoff) can reduce FPR at the
expense of Recall (data not shown).
Case 5 is an example of a gene with high variability in
both classes, which should ideally not be identified as dif-
ferentially expressed. Here, there does not appear to be a
significant difference in the distribution of inter-class and
intra-class ratios, as seen in Figure 2B. PPRM has FPR of
0.02% which is the lowest, followed by the t test and PPST
at 1%. COPA, OS, ORT and MOST have a FPR of 11%.
(Note: Not accounting for variability in class N by PPRM
has a FPR of 7%. This FPR decreases as the values of CTN
and CTT are increased)
In summary, in cases where the heterogeneity in the sam-
ple population is low as exemplified by Case 1, all tests
except COPA and OS perform reasonably well in identify-
ing true positives. The t test, PPST, COPA and OS fail to
identify differentially expressed genes in most cases,
whereas PPRM, ORT and MOST can identify most differ-
entially expressed genes in all cases. However, though
ORT and MOST give lower FPR for case 4, they give higher
FPRs than PPRM in Case 2 and 5 representing non differ-
entially expressed genes.
In the case of simulated data, the inter-class and intra-class
ratios were chosen based on knowledge of expression lev-
els of truly differentially expressed genes, which will
clearly not be the case in real world data. However, for
real-world data, these parameters will be chosen based on
the requirement of specific types of genes. More than one
set of parameters can be used for an analysis to obtain dif-
ferent groups of differentially expressed genes. For exam-
ple, using low intra-class cutoffs allows the identification
of differentially expressed genes with low intra-class vari-
ability whereas using a higher value of one intra-class cut-
off (CTT  or CNN) also identifies genes with higher
heterogeneity in that group (T or N, respectively).
Experimental Data
Variability in simulated data cannot mimic the heteroge-
neity in real biological data, and hence PPRM is also
tested on the following three publicly available experi-
mental data sets. Since there is no gold standard of a list
of differentially expressed genes in real world data, simply
identifying differentially expressed genes in a data set is
not adequate to test the method. Though the distinguish-
ing feature of PPRM lies in its ability to identify differen-
tially expressed genes with greater variability between
samples in a class, the method is also able to identify dif-
ferentially expressed with low variability within groups
based on the choice of parameters used for the test. Hence,
in analyzing real biological data, an approach of identify-
ing a relatively small number of 'predictor' genes is
adopted and their accuracy in being able to predict the
class of an unknown sample is tested. This approach of
validation of new methods of identification of differen-
tially expressed genes has also been used by other
researchers [38]. The classification accuracy is expected to
be similar to other reported values, but not necessarily
better since the primary goal of this report is not to iden-
tify genes for classification.
In order to identify biomarkers, stringent conditions are
used (i.e. higher values of inter-class ratio cut-off, lower
value of intra-class ratio cutoff and lower values of cutoff
of the p-value) to select a small number of genes with low
heterogeneity in expression within a class. For the biolog-
ical data sets used below, misclassification rates reported
using some other methods are included for the sake of
general comparison. For the leukemia data set, the inde-
pendent data set available is used to test the prediction
power of selected genes. For all other data sets, a LOOCV
technique is used. To avoid bias in gene selection from the
sample which is left out, the list of differentially expressed
genes is calculated separately every time with the same
parameters, and this list is used to predict the class of the
sample that is left out. Classification is performed using
Discriminant Analysis in Matlab (The Mathworks, Inc.,
Natick, MA, USA).
Leukemia data
Gene expression profiles of two types of leukemia samples
were derived from 47 patients with acute lymphoblastic
leukemia (ALL) and 25 patients with acute myeloblastic
leukemia by Golub et al [18]. Data is obtained from the
Broad Institute website at http://www.broad.mit.edu/cgi-
bin/cancer/datasets.cgi.BMC Bioinformatics 2008, 9:380 http://www.biomedcentral.com/1471-2105/9/380
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The training data consists of gene expression data from 27
patients with acute lymphoblastic leukemia (ALL) and 11
patients with acute myeloblastic leukemia (AML) while
the independent data set consisted of 20 ALL samples and
14 AML samples. Genes for which less than 5 samples had
a "Present" call were not used in the analysis. The values
of the three parameters for PPRM are listed in Table 4. In
the original publication by Golub et al [18], the authors
identified 50 genes as biomarkers based on their method
of neighborhood analysis, and tested the use of these
genes to predict the class of samples in the independent
data set. They correctly classified all samples on which a
prediction is made, 29 out of 34, declining to predict the
other five. Using a support vector machine method, Furey
et al [49] could correctly classify 30 to 32 out of the 34
samples. Using the parameters listed in Table 4, six differ-
entially expressed genes were identified using PPRM.
These genes were used as biomarkers to test the accuracy
of class prediction for samples in the independent data
set. Out of the 34 samples, 33 were accurately classified
using the 6 genes identified by PPRM.
Prostate cancer data
The prostate cancer data set generated by Singh et al [48]
consists of 92 samples, 45 of which were non-tumor pros-
tate samples and 47 of which were prostate tumor. The
data set is publicly available and is obtained from the
Broad Institute website http://www.broad.mit.edu/cgi-
bin/cancer/datasets.cgi. Genes for which less than 20 sam-
ples had a "Present" call were not used in the analysis. A
LOOCV technique is used for this data set. In the original
paper, a 10% error rate in sample classification using
LOOCV is obtained, while Dettling et al [50] reported
misclassification rates between 5%–14% using supervised
clustering. In this study, using the parameters listed in
Table 4, an 8% error rate in sample classification using
LOOCV is obtained. The number of biomarker genes
identified in all LOOCV runs is between 9 and 18.
Colon cancer data
The colon cancer data set generated by Alon et al. [47]con-
sists of 62 samples, 40 tumor samples and 22 normal con-
trols. The gene expression data were downloaded from
http://microarray.princeton.edu/oncology/affydata/
index.html. LOOCV is also used for this data set. Other
researchers have obtained misclassification rates (includ-
ing unclassified samples) between 8% to 34% [50-54]
using various methods like nearest neighbor classifiers,
SVM, boosting, 'Minimum Redundancy- Maximum Rele-
vancy', Bayes error filter for gene selection and supervised
clustering.
In this study, using the parameters listed in Table 4, a 16%
error rate in sample classification using the LOOCV is
obtained. The number of biomarker genes identified in all
LOOCV validation runs is between 7 and 13, with one
exception where 23 genes were identified.
Discussion
DNA microarray analysis is being increasingly used to
identify differences between two or more classes like dis-
eased and healthy tissue. Most methods used for the iden-
tification of differentially expressed genes between two
classes identify genes where the variability between sam-
ples in a class is low. However there can be significant var-
iability among samples in a class due to differences
between individual subjects and their environment [36].
PPRM uses inter-sample ratios to quantify variability in
expression. This method allows for the identification of
genes where the user can define the allowable heterogene-
ity within one or both classes and required difference in
expression between samples in the two classes. Since all
inter-class and intra-class ratios used in this method are
not independent, the significance values calculated by
PPRM are not exact and should be used only for ranking
and prioritizing genes. The mean and standard deviation
of the test statistic are reported for the simulated data sets
to facilitate the assessment of the impact of violation of
the assumptions for the sample size of 10 samples in each
class (i.e. 100 inter-class ratios and 45 intra-class ratios for
each class, out of which 19 and 9 respectively are inde-
pendent).
PPRM works as well or better than all other methods
tested in data sets where the heterogeneity in samples is
low. In simulated cases tested where variability is high,
ORT, MOST and PPRM successfully identify most differ-
entially expressed genes. In addition to a high Recall, it is
necessary for any method to minimize the number of false
positives identified. Genes with high variability in expres-
sion levels among samples in both classes should not be
identified as differentially expressed simply because the
expression level in some samples in one class is different
than the expression level of some samples in the other
class. This is tested in case 2 and 5 in the simulated data,
where reassuringly a very low FPR of 0.2 and 0.02% is
obtained using PPRM. However, for these cases ORT and
MOST consistently resulted in higher values of the test sta-
tistic for the 1000 non differentially expressed genes
resulting in high FPRs. This is likely due to the lack of an
Table 4: Parameters used for the analysis of the three cancer 
data sets
Parameter Leukemia Prostate Cancer Colon cancer
CTN 2 3.5 3
CTT 1.5 2 3
CNN 1.5 2 -
pcutoff 0.0001 0.001 1e-10BMC Bioinformatics 2008, 9:380 http://www.biomedcentral.com/1471-2105/9/380
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additional constraint of relative difference in these meth-
ods as available in PPRM.
PPRM is also able to identify differentially expressed with
low variability within groups, based on the choice of
parameters used for the test. Hence, it is possible to test it
on publicly available cancer data sets by assessing the suc-
cess of the genes identified in correctly classifying samples
in the two groups. The classification accuracies obtained
for the three publicly available cancer data sets used for
testing are similar to those reported using other methods.
Conclusion
The Population Proportion Ranking Method (PPRM) pre-
sented here quantifies variability in terms of inter-sample
ratios and allows for the identification of genes where the
user can define the allowable heterogeneity within one or
both classes and required difference in expression
between samples in the two classes for ranking differen-
tially expressed genes.
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